Anderson Cynthia Lynn 4
4 · Vistagen Therapeutics, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Anderson Cynthia Lynn
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2024-06-28$2.96/sh+3,592$10,625→ 3,592 total
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended.